Concert Pharmaceuticals
Mr. Daniel Morse joined Concert in January 2016 and currently serves as Vice President, Global Supply Chain. He has over 25 years of supply chain experience in the pharmaceutical industry. Prior to joining Concert, Mr. Morse was Head of Clinical Supply Chain at Ariad Pharmaceuticals. Before joining Ariad, Mr. Morse held supply chain management roles at several companies including AVEO, Vertex Pharmaceuticals, Wyeth BioPharma and Genetics Institute. Mr. Morse began his career at Immulogic Pharmaceuticals. He received a B.S. in Biology from Northeastern University.
This person is not in any offices
Concert Pharmaceuticals
Concert Pharmaceuticals is a clinical-stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel medicines designed to address unmet patient needs.